Director Global Health Economics & Outcomes Research

Overview

In this role you will lead global health economics and outcomes research activities to generate value evidence for Ipsen’s portfolio across oncology, neuroscience and rare diseases. You will collaborate with cross-functional partners to shape payer communications, HTA submissions, and evidence plans from early development through launch and mature stages. You will drive RWE, PROs, and economic modeling to support access and pricing decisions. This position offers a chance to influence global access strategies and work on high-impact, patient-centered outcomes.

Responsibilities

• Lead launch readiness, post-launch updates, and core HEOR/Access deliverables (literature reviews, burden of illness, unmet needs, outcomes, guidelines, comparative effectiveness, network meta-analyses, cost-effectiveness and budget impact models, Global Value Dossiers, payer propositions, objection handlers)
• Plan and execute EU HTA Regulation JCA activities as applicable to product assignments
• Support payer value evidence communication through abstracts, posters, and manuscripts at conferences
• Contribute to Integrated Evidence Generation Plans across Ipsen products with cross-functional alignment
• Lead and inform RWE, health outcomes/PROs strategies and execution to strengthen value propositions
• Inform pipeline target product and value profiles and clinical development plans including payer-relevant endpoints
• Support development of pricing policy and market access for Ipsen products
• Collaborate with local affiliates and global teams (Medical Affairs, Regulatory, Clinical, Biostatistics, Public Affairs, Marketing)
• Stay updated on payer/HTA landscape and trends to guide strategic HEOR planning
• Provide training on value evidence for local adaptation by country teams

Key requirements

• At least 8 years of HEOR experience in pharma, consultancy, or academia, in an international setting
• Experience with international HTA submissions
• Strong scientific analysis, interpretation, and writing skills
• Knowledge of international health care systems
• Experience in Oncology, Rare Disease, and/or Neuroscience HEOR including evidence synthesis, cost-effectiveness, budget impact modeling, RWE methodologies, PROs
• Knowledge of trial design and key clinical, PRO, and resource utilization endpoints

• Collaborative mindset
• Strategic thinking
• Excellent written and oral communication
• HEOR strategy and execution
• Evidence synthesis and meta-analysis
• Cost-effectiveness analysis (CEA)

…